ELAN
Price
$18.43
Change
+$0.96 (+5.50%)
Updated
Sep 5 closing price
Capitalization
9.16B
66 days until earnings call
PBH
Price
$65.05
Change
-$1.70 (-2.55%)
Updated
Sep 5 closing price
Capitalization
3.2B
54 days until earnings call
Interact to see
Advertisement

ELAN vs PBH

Header iconELAN vs PBH Comparison
Open Charts ELAN vs PBHBanner chart's image
Elanco Animal Health
Price$18.43
Change+$0.96 (+5.50%)
Volume$6.92M
Capitalization9.16B
Prestige Consumer Healthcare
Price$65.05
Change-$1.70 (-2.55%)
Volume$693.52K
Capitalization3.2B
ELAN vs PBH Comparison Chart in %
Loading...
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELAN vs. PBH commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELAN is a StrongBuy and PBH is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ELAN: $18.43 vs. PBH: $65.05)
Brand notoriety: ELAN: Notable vs. PBH: Not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ELAN: 91% vs. PBH: 133%
Market capitalization -- ELAN: $9.16B vs. PBH: $3.2B
ELAN [@Pharmaceuticals: Generic] is valued at $9.16B. PBH’s [@Pharmaceuticals: Generic] market capitalization is $3.2B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELAN’s FA Score shows that 0 FA rating(s) are green whilePBH’s FA Score has 0 green FA rating(s).

  • ELAN’s FA Score: 0 green, 5 red.
  • PBH’s FA Score: 0 green, 5 red.
According to our system of comparison, PBH is a better buy in the long-term than ELAN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELAN’s TA Score shows that 5 TA indicator(s) are bullish while PBH’s TA Score has 3 bullish TA indicator(s).

  • ELAN’s TA Score: 5 bullish, 4 bearish.
  • PBH’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ELAN is a better buy in the short-term than PBH.

Price Growth

ELAN (@Pharmaceuticals: Generic) experienced а +0.44% price change this week, while PBH (@Pharmaceuticals: Generic) price change was -4.39% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

ELAN is expected to report earnings on Nov 11, 2025.

PBH is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELAN($9.16B) has a higher market cap than PBH($3.2B). ELAN has higher P/E ratio than PBH: ELAN (20.94) vs PBH (15.27). ELAN YTD gains are higher at: 52.188 vs. PBH (-16.699). ELAN has higher annual earnings (EBITDA): 1.45B vs. PBH (362M). ELAN has more cash in the bank: 539M vs. PBH (140M). PBH has less debt than ELAN: PBH (1.04B) vs ELAN (4.21B). ELAN has higher revenues than PBH: ELAN (4.48B) vs PBH (1.12B).
ELANPBHELAN / PBH
Capitalization9.16B3.2B286%
EBITDA1.45B362M400%
Gain YTD52.188-16.699-313%
P/E Ratio20.9415.27137%
Revenue4.48B1.12B400%
Total Cash539M140M385%
Total Debt4.21B1.04B404%
FUNDAMENTALS RATINGS
ELAN vs PBH: Fundamental Ratings
ELAN
PBH
OUTLOOK RATING
1..100
578
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
84
Overvalued
PROFIT vs RISK RATING
1..100
10044
SMR RATING
1..100
7962
PRICE GROWTH RATING
1..100
3985
P/E GROWTH RATING
1..100
9172
SEASONALITY SCORE
1..100
2950

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PBH's Valuation (84) in the Pharmaceuticals Other industry is in the same range as ELAN (93) in the Agricultural Commodities Or Milling industry. This means that PBH’s stock grew similarly to ELAN’s over the last 12 months.

PBH's Profit vs Risk Rating (44) in the Pharmaceuticals Other industry is somewhat better than the same rating for ELAN (100) in the Agricultural Commodities Or Milling industry. This means that PBH’s stock grew somewhat faster than ELAN’s over the last 12 months.

PBH's SMR Rating (62) in the Pharmaceuticals Other industry is in the same range as ELAN (79) in the Agricultural Commodities Or Milling industry. This means that PBH’s stock grew similarly to ELAN’s over the last 12 months.

ELAN's Price Growth Rating (39) in the Agricultural Commodities Or Milling industry is somewhat better than the same rating for PBH (85) in the Pharmaceuticals Other industry. This means that ELAN’s stock grew somewhat faster than PBH’s over the last 12 months.

PBH's P/E Growth Rating (72) in the Pharmaceuticals Other industry is in the same range as ELAN (91) in the Agricultural Commodities Or Milling industry. This means that PBH’s stock grew similarly to ELAN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ELANPBH
RSI
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
57%
Momentum
ODDS (%)
Bullish Trend 2 days ago
59%
Bearish Trend 2 days ago
52%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
55%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
53%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
45%
Advances
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 9 days ago
57%
Declines
ODDS (%)
Bearish Trend 4 days ago
74%
Bearish Trend 2 days ago
52%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
57%
Aroon
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
43%
View a ticker or compare two or three
Interact to see
Advertisement
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LICCX17.62N/A
N/A
Lord Abbett International Equity C
VTMGX18.86N/A
N/A
Vanguard Developed Markets Index Admiral
ISJBX19.83N/A
N/A
Voya US Stock Index Port S
CFXRX14.93N/A
N/A
Columbia Flexible Capital Income Inst2
RMBBX16.80N/A
N/A
RMB Small Cap I

ELAN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELAN has been loosely correlated with VTRS. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ELAN jumps, then VTRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAN
1D Price
Change %
ELAN100%
+5.50%
VTRS - ELAN
53%
Loosely correlated
+1.65%
ZTS - ELAN
46%
Loosely correlated
+0.08%
SNDL - ELAN
39%
Loosely correlated
+1.64%
PAHC - ELAN
37%
Loosely correlated
+0.97%
TLRY - ELAN
36%
Loosely correlated
+3.48%
More